FDA recalls La Roche-Posay, Proactiv, Walgreens acne products, benzene contamination issues

Read Time:1 Minute, 23 Second

After testing, the U.S. Food and Drug Administration (FDA) announced a recall of selected acne treatment products, finding elevated benzene levels, a cancer-related chemical. The agency tested 95 benzoyl peroxide acne products and found that over 90% of benzoylbenzene levels were not high or very low. However, six products showed a high enough pollution level to prompt a recall at retail levels. Recalls are limited to retailers, meaning stores have been instructed to remove affected products from shelves and online marketplaces. Consumers do not need to take any specific action on the products they already own. However, the FDA recommends discarding any products that are past their expiration dates.Recalled Products: La Roche-Posay Effaclar Duo Dual Action Acne Treatment (Lot: MYX46W, Exp. April 2025) Walgreens Acne Control Cleanser (Lot: 23 09328, Exp. September 2025) Proactiv Emergency Blemish Relief Cream Benzoyl Peroxide 5% (Lots: V3305A, V3304A, Exp. Its manufacturers voluntarily recalled after their own internal tests and found elevated benzene levels. The FDA stressed that the risk of developing cancer from benzene exposure even through benzene exposure, even if used daily for many years, is considered very low. Consumers are encouraged to check the batch number and expiration date of their acne products. Expired products should be discarded, especially those from the affected recall list. The FDA urges healthcare professionals and consumers to report any adverse reactions or quality issues related to benzoyl carbon dioxide acne treatment through its MEDWATCH adverse event reporting program. For additional information about recalls and updates, visit the FDA's Drug Recall page, visit the FDA's DATA DATA recall fda ersecss.

Source link